Beyond the Off-Label: A Systematic Review of What We Know About Clozapine Use for Children

被引:2
|
作者
Pimenta de Figueiredo, Thales [1 ]
de Almeida, Igor Ribeiro [1 ]
de Freitas, Filipe Augusto Cursino [2 ]
Kubrusly, Caio Hage Chahine [1 ]
Alvim-Soares Jr, Antonio Marcos [1 ]
de Miranda, Debora Marques [1 ]
机构
[1] Univ Fed Minas Gerais, 190 Ave Prof Alfredo Balena, BR-30130100 Belo Horizonte, MG, Brazil
[2] Fundacao Hosp Estado Minas Gerais, Belo Horizonte, Brazil
关键词
clozapine; children; psychopharmacology; aggressive behavior; DOUBLE-BLIND; ADOLESCENTS; ANTIPSYCHOTICS; AGGRESSION; DISORDER; YOUTHS;
D O I
10.1089/cap.2024.0070
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: It is essential not to delay behavior management and control for aggression, violence, and impulsive behavior in young people. Clozapine has been widely used in adolescents and adults to manage violence and aggression in Schizophrenia. However, there are limited data on the use of clozapine in children, and no systematic review has addressed its use in this population.Objective and Methods: To better understand the conditions under which clozapine is used as a therapeutic alternative for nonschizophrenic diagnoses and to assess the current evidence supporting its prescription to children, a systematic review was conducted. The review followed PRISMA guidelines and was registered in PROSPERO under the ID CRD42024537707.Results: The review identified that all the studies used clozapine to address externalizing behavior, particularly aggressive behavior, and found positive outcomes supporting its use for treating children with treatment-resistant aggression. The studies also found that clozapine was well-tolerated in all cases. However, the studies were limited and mainly consisted of open trials without a control group.Conclusion: Further high-quality research is needed to establish precise guidelines for using clozapine in children.
引用
收藏
页码:e419 / e426
页数:8
相关论文
共 50 条
  • [31] What Do We Know About Intraoperative Teaching? A Systematic Review
    Timberlake, Matthew D.
    Mayo, Helen G.
    Scott, Lauren
    Weis, Joshua
    Gardner, Aimee K.
    ANNALS OF SURGERY, 2017, 266 (02) : 251 - 259
  • [32] Currents questions about off-label use - Reply
    Dierks, C
    Nitz, G
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (08) : 397 - 398
  • [33] What we know and what we don't know about perinatal Zika virus infection: a systematic review
    Soriano-Arandes, Antoni
    Rivero-Calle, Irene
    Nastouli, Eleni
    Espiau, Maria
    Frick, M. A.
    Alarcon, Ana
    Martinon-Torres, Federico
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (03) : 243 - 254
  • [34] Reflections About Off-label Use of Anticancer Drugs
    Tartarone, Alfredo
    Lerose, Rosa
    Aieta, Michele
    THERAPEUTIC DRUG MONITORING, 2012, 34 (05) : 604 - 604
  • [35] A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases
    Ramos-Casals, Manuel
    Brito-Zeron, Pilar
    Munoz, Sandra
    Soto, Maria-Jose
    MEDICINE, 2008, 87 (06) : 345 - 364
  • [36] Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review
    Joana Magalhães
    António Teixeira Rodrigues
    Fátima Roque
    Adolfo Figueiras
    Amílcar Falcão
    Maria Teresa Herdeiro
    European Journal of Clinical Pharmacology, 2015, 71 : 1 - 13
  • [37] Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review
    Magalhes, Joana
    Rodrigues, Antnio Teixeira
    Roque, Fatima
    Figueiras, Adolfo
    Falco, Amilcar
    Herdeiro, Maria Teresa
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (01) : 1 - 13
  • [38] Off-label indications for atypical antipsychotics: A systematic review
    Fountoulakis K.N.
    Nimatoudis I.
    Iacovides A.
    Kaprinis G.
    Annals of General Hospital Psychiatry, 3 (1):
  • [39] Off-Label indications for atypical antipsychotics: a systematic review
    KN Fountoulakis
    I Nimatoudis
    A Iacovides
    G Kaprinis
    Annals of General Hospital Psychiatry, 2 (Suppl 1):
  • [40] Off-label indications for atypical antipsychotics: A systematic review
    Fountoulakis, K
    Nimatoudis, I
    Iacovides
    Kaprinis, S
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S281 - S281